我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

低密度脂蛋白胆固醇抗体对急性冠脉综合征患者的保护机制

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第3期
页码:
282-288
栏目:
临床研究
出版日期:
2018-03-25

文章信息/Info

Title:
Protection mechanism of autoantibodies against ox-LDL in ACS patients
作者:
刘鸿涛1; 彭昱东2; 邓 霞1; 宋宗仁1; 张 乐1; 何文平1; 余学东1 ; 曾秋棠2
（1.深圳市龙华区中心医院、广东医科大学附属龙华中心医院心血管内科，广东 深圳 518110；2.华中科技大学同济医学院附属协和医院心血管病研究所，湖北 武汉 430022）
Author(s):
LIU Hong-tao1;  PENG Yu-dong2;  DENG Xia1;  SONG Zhong-ren1;  ZHANG Le1;  HE Wen-ping1;  YU Xue-dong1;  ZENG Qiu-tang2
(1.Departmeng of Cardiovascular Medicine, Shenzhen Longhua District Central Hospital, Longhua Central Hospital Affiliated Guangdong Medical University, Shenzhen 518110, Guangdong, China; 2.Department of Cardiovascular Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, Hubei, China)
关键词:
急性冠脉综合征; 氧化低密度脂蛋白; 免疫漂移; 再灌注
Keywords:
acute coronary syndrome;  ox-LDL;  Immune drift;  reperfusion
分类号:
R540
DOI:
-
文献标识码:
A
摘要:
目的 阐明急性冠脉综合征（ACS）患者急性期趋化因子配体［chemokine(C-C motif)ligand,CCL)5和白细胞介素(IL)-18波动与ox-LDL自身抗体的关系，T淋巴细胞的免疫漂移规律；以及观察不同的再灌注治疗策略对减轻炎症反应的作用。方法 入选对照组（n=30）：冠状动脉造影阴性人员。随机序贯入选60位ACS患者，将其分为两组：早期再灌注（ER，n=29）组和晚期再灌注（LR，n=31）组。所有患者均进行冠脉造影，并采集入院后第 2天至第28天的静脉血液样本，测定指标包括：血脂水平：总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）和ox-LDL，炎症因子：CCL5、IL-18、IL-33、IL-5和超敏C反应蛋白（hs-CRP），血浆免疫球蛋白（Ig）亚型，及分析Th1［CD4+γ干扰素(IFN-γ)+］和Th2(CD4+IL-4+)细胞亚群。结果 ①炎症因子：CCL5：ER组在第8天出现下降，而LR组在第14天出现下降，IL-18：ER组在第8天达到峰值，而LR组则在第12天达到峰值，IL-5和IL-33：ER组的曲线拐点出现在第4天，而LR组出现在第16天，hs-CRP：ER组的第4天出现下降而LR组在第14天出现下降。②血脂水平:4周内对照组的血脂水平（TC、TG、LDL和ox-LDL）没有明显变化，两种不同的再灌注策略中，血脂没有明显差异。③免疫漂移：ER组和LR组第1周T淋巴细胞免疫漂移最为显著。Th1漂移出现明显缓解，Th1漂移现象分别在ER组第2周和LR组第3周开始出现，并于第4周两组的Th1/Th2值最终趋于相等。与LR组比较，ER组前2周产生更多总IgA、IgE、IgG1，但两组在总IgG2a和IgM水平上几乎完全相等。重要的是，前两周中ER组中ox-LDL的IgG1抗体显著升高，而在ox-LDL的IgM抗体方面，ER和LR组之间没有显著差异。④相关性和线性回归分析：上述连续变量的相关性研究发现，血浆浓度CCL5与IL-18，IL-33与IL-5明显正相关性（P<0.01）。多元线性回归分析表明，CCL5、ox-LDL和hs-CRP正相关，而IL-33、ox-LDL抗体与hs-CRP水平负相关。结论 与LR治疗相比，ER治疗策略能明显降低不稳定斑块的附加风险, 可能优于晚期再灌注治疗。
Abstract:
AIM The first aim was to clarify whether CCL5 and IL-18 are accompanied with autoantibodies against ox-LDL activity and T-lymphocyte immune drift in ACS patients. A secondary aim was to investigate the extent of different reperfusion therapeutic strategies to alleviate inflammation. METHODS The present investigation recruited 30 coronary angiography negative persons as ①control group (n=30), and studied a total of 60 consecutive unselected ACS patients divided into other two groups: ②early reperfusion (ER) group and ③Late reperfusion (LR, after 2 weeks) combinated group. All patients had coronary angiography and venous blood samples of all participants were drawn every morning from day 2 to 28 after admission. Detection index including: blood fat index (TC, TG, HDL-C, LDL-C and ox-LDL), inflammation index (CCL5, IL-18, IL-33, IL-5 and hs-CRP), Plasma Ig isotypes, and analysis of Th1 (CD4+IFNγ+), Th2 (CD4+IL4+) by flow cytometry. RESULTS ①Blood lipid fluctuation: The blood lipid levels (TC, TG, LDL and ox-LDL) of the control group had little change during the 4 weeks (P>0.05). Between the two different reperfusion strategies, there was no differences in improvement of blood lipids metabolism (P>0.05). ②Inflammatory cytokines dynamic state; CCL5 decreases in the ER group were demonstrated at day 8, but in the LR group not until day 14. IL-18 reached a maximum at day 8 in the ER group but peaked at day 12 in the LR group. IL-5 and IL-33 appeared at day 4 in the ER group but were seen at day 16 in the LR group. hsCRP decreased in the ER group at day 4 but not until day 14 in the LR group. ③T-lymphocyte immune drift state: Flow cytometry showed that T lymphocyte subsets: both in the ER group and the LR group, T-lymphocyte immune drift was the most significant in the first week. Th1 bias who was relieved markedly from the beginning of the second week in ER group and from the third week in LR group evolved eventually toward an almost equal value of Th1/Th2 in the two treatment groups at the fourth week. The results showed that the ER group produced more total IgA, IgE, and IgG1 in the first 2 weeks, but total IgG2a and IgM in the ER group were almost equal with that in the LR group. Importantly, significantly elevated IgG1 antibody of ox-LDL were demonstrated at the ER group in the first 2 weeks, but IgM antibody of ox-LDL did not demonstrate significant differences between the ER and the LR groups. ④Correlation analysis was performed for continuous variables and found that plasma concentration of CCL5 with IL-18, IL-33 with IL-5 had clear association (P<0.01). Multiple linear regression analysis showed that CCL5 and ox-LDL had positive relationships with hsCRP, but IL-33 and ox-LDL antibody maintained negtive predictors with hs-CRP. CONCLUSION Early reperfusion strategy significantly alleviates the additional risk of plaque vulnerability compared with late reperfusion treatment and efficacy of early reperfusion strategy maybe better than late reperfusion treatment

参考文献/References

[1]Peng YD,Cheng LX,Zeng QT,et al.The role of RANTES as a crucial downstream cytokine in calcineurin-dependent VSMC apoptosis stimulated by INFgamma and CD40L[J].Cell Biol Int,2010,34(6):447-453.

[2]van Bruggen N,Ouyang W.Th17 cells at the crossroads of autoimmunity, inflammation, and atherosclerosis[J].Immunity,2014,40(1):10-12.

[3]Alfaleh HF,Alhabib KF,Kashour T,et al.Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2[J].Coron Artery Dis,2014,25(24):330-338.

[4]de Jager SC,Bongaerts BW,Weber M,et al.Chemokines CCL3/MIP1alpha, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes[J].PLoS One,2012,7(11):e45804.

[5]Liu H,Ning H,Men HC,et al.Regulation of CCL5 expression in smooth muscle cells following arterial injury[J].PLoS One,2012,7(7):e30873.

[6]Moohebati M,Kabirirad V,Ghayour-Mobarhan M,et al.Investigation of Serum Oxidized Low-Density Lipoprotein IgG Levels in Patients with Angiographically Defined Coronary Artery Disease[J].Int J Vasc Med,2014,2014:845960.

[7]O’Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Circulation,2013,127(5):e362-e425.

[8]Cheng X,Liao YH,Ge H,et al.TH1/TH2 functional imbalance after acute myocardial infarction:coronary arterial inflammation or myocardial inflammation[J].J Clin Immunol,2005,25(8):246-253.

[9]Yao L,Herlea-Pana O,Heuser-Baker J,et al.Roles of the chemokine system in development of obesity,insulin resistance,and cardiovascular disease[J].J Immunol Res,2014,2014:181450.

[10]Zhang YC,Wei JJ,Wang F,et al.Elevated Levels of Oxidized Low-Density Lipoprotein Correlate Positively with C-Reactive Protein in Patients with Acute Coronary Syndrome[J].Cell Biochem Biophys,2012,62(6):365-372.

[11]刘晓红,洪苍浩,汤国法,等.氧化低密度脂蛋白、高敏C反应蛋白与冠状动脉支架置入术后再狭窄的关系[J].临床心血管病杂志,2010,26(5):326-328.

备注/Memo

备注/Memo:
收稿日期：2017-03-26.基金项目：湖北省自然科学基金项目资助（2013CFB070） 通讯作者：彭昱东，副教授，主要从事冠心病介入与临床研究 Email：am-penicillin@163.com 作者简介：刘鸿涛，副主任医师，硕士 Email：lht1376@163.com
更新日期/Last Update: 1900-01-01